Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (17)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dancey, D. R.
Right arrow Articles by Downey, G. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dancey, D. R.
Right arrow Articles by Downey, G. P.
(Chest. 2000;118:1210-1214.)
© 2000 American College of Chest Physicians

Successful Treatment of Juvenile Laryngeal Papillomatosis-Related Multicystic Lung Disease With Cidofovir* Case Report and Review of the Literature

David R. Dancey, MD; Dean W. Chamberlain, MD; Mel Krajden, MD{dagger}; Joel Palefsky, MD; P.W. Alberti, MD and Gregory P. Downey, MD, FCCP

* From the Division of Respirology (Drs. Dancey and Downey) and the Division of Medical Microbiology (Dr. Krajden), Department of Medicine, the Department of Laboratory Medicine and Pathobiology (Dr. Chamberlain), and the Division of Otolaryngology (Dr. Alberti), Department of Surgery, University of Toronto, Ontario, Canada; and the Department of Laboratory Medicine (Dr. Palefsky), University of California, San Francisco, CA. {dagger} Current address: Provincial Lab, British Columbia Centre for Disease Control, Vancouver, British Colombia, Canada.

Correspondence to: Gregory P. Downey, MD, FCCP, EN 10–212, The Toronto General Hospital, 200 Elizabeth St, Toronto, Ontario, Canada M5G 2C4; e-mail: gregory.downey{at}utoronto.ca

Cidofovir, a nucleoside analog antiviral agent, has been used with moderate success in the treatment of juvenile laryngeal papillomatosis (JLP) by direct intralesional injection. We report the first case where IV cidofovir was used successfully to treat a rare but lethal multicystic lung disease complicating JLP. A 35-year-old woman with a history of JLP requiring multiple laser ablations of laryngeal papillomata each year presented with hemoptysis and was found on CT scan to have bilateral, multiple pulmonary nodules and cysts. The results of BAL fluid analysis demonstrated no evidence of malignancy, and cultures were negative for fungi and mycobacteria. Molecular DNA typing of a biopsy specimen obtained from a laryngeal papilloma confirmed infection with human papilloma virus type 11. She received 12 months of treatment with IV cidofovir followed by 9 months of combined treatmentwith IV cidofovir and subcutaneous interferon-{alpha}-2A. This therapeutic regime resulted in a markedly decreased requirement for surgical removal of laryngeal papillomata, and CT scanning documented the regression of the lesions in the lung parenchyma that persisted after the discontinuation of therapy. The results of this case demonstrate that cidofovir may be used successfully to treat JLP-related lung disease and suggest that further studies are warranted.

Key Words: cidofovir • human papilloma virus • interferon • juvenile laryngeal papillomatosis




This article has been cited by other articles:


Home page
Am J Health Syst PharmHome page
G. Hennere, L. Havard, B. Bonan, and P. Prognon
Stability of cidofovir in extemporaneously prepared syringes
Am. J. Health Syst. Pharm., March 1, 2005; 62(5): 506 - 509.
[Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
E. De Clercq
Clinical Potential of the Acyclic Nucleoside Phosphonates Cidofovir, Adefovir, and Tenofovir in Treatment of DNA Virus and Retrovirus Infections
Clin. Microbiol. Rev., October 1, 2003; 16(4): 569 - 596.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
C. J. McNamee, D. Lien, L. Puttagunta, and A. A. Conlan
Solitary squamous papillomas of the bronchus: a case report and literature review
J. Thorac. Cardiovasc. Surg., September 1, 2003; 126(3): 861 - 863.
[Full Text] [PDF]


Home page
Arch Otolaryngol Head Neck SurgHome page
L. M. Akst, W. Lee, C. Discolo, D. Knott, A. Younes, and P. J. Koltai
Stepped-Dose Protocol of Cidofovir Therapy in Recurrent Respiratory Papillomatosis in Children
Arch Otolaryngol Head Neck Surg, August 1, 2003; 129(8): 841 - 846.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
N. J. C. Snell
New treatments for viral respiratory tract infections--opportunities and problems
J. Antimicrob. Chemother., March 1, 2001; 47(3): 251 - 259.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the American College of Chest Physicians.